Founded in 2013, BioAscent is a leading provider of integrated drug discovery services based at the former Organon R&D site in Newhouse, Scotland, UK. BioAscent currently holds and manages over 1 million compounds for our Compound Management customers, in both liquid and solid formats. Through our Compound Cloud service, we provide rapid access to an IP-free library of ~125,000 lead like compounds in screening-ready format. Our drug discovery services include assay development, screening, medicinal and synthetic chemistry, and computational chemistry. Our team of expert scientists has experience of successfully working from assay development through to candidates across all biological target classes.
Newhouse, ML1 5UH United Kingdom